These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis. Kojima F, Uchida K, Ogawa T, Tanaka Y, Nitta K. Int Urol Nephrol; 2008; 40(4):1067-74. PubMed ID: 18791804 [Abstract] [Full Text] [Related]
23. Iron, coronary artery calcification, and mortality in patients undergoing hemodialysis. Mizuiri S, Nishizawa Y, Doi T, Yamashita K, Shigemoto K, Usui K, Arita M, Naito T, Doi S, Masaki T. Ren Fail; 2021 Dec; 43(1):371-380. PubMed ID: 33596750 [Abstract] [Full Text] [Related]
29. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. Sillesen H, Muntendam P, Adourian A, Entrekin R, Garcia M, Falk E, Fuster V. JACC Cardiovasc Imaging; 2012 Jul; 5(7):681-9. PubMed ID: 22789936 [Abstract] [Full Text] [Related]
30. Radiographic assessment of vascular calcification, aortic pulse wave velocity, ankle-brachial index and fibroblast growth factor-23 in chronic hemodialysis patients. Breznik S, Ekart R, Hren M, Rupreht M, Balon BP. Ther Apher Dial; 2013 Aug; 17(4):378-83. PubMed ID: 23931875 [Abstract] [Full Text] [Related]
32. Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients. Kirkpantur A, Altun B, Hazirolan T, Akata D, Arici M, Kirazli S, Turgan C. Artif Organs; 2009 Oct; 33(10):844-54. PubMed ID: 19681840 [Abstract] [Full Text] [Related]
33. Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Inaba M, Okuno S, Imanishi Y, Yamada S, Shioi A, Yamakawa T, Ishimura E, Nishizawa Y. Osteoporos Int; 2006 Oct; 17(10):1506-13. PubMed ID: 16896512 [Abstract] [Full Text] [Related]
34. High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification. Fu X, Cui QQ, Ning JP, Fu SS, Liao XH. Med Sci Monit; 2015 Nov 11; 21():3467-73. PubMed ID: 26558428 [Abstract] [Full Text] [Related]
36. Serum S100A12 and Progression of Coronary Artery Calcification Over 4 Years in Hemodialysis Patients. Wang YN, Sun Y, Wang Y, Jia YL. Am J Nephrol; 2015 Nov 11; 42(1):4-13. PubMed ID: 26278922 [Abstract] [Full Text] [Related]
39. Assessment of the relationship between selected cardiovascular risk factors and the indices of intima-media thickness and coronary artery calcium score in various stages of chronic kidney disease. Szarejko-Paradowska A, Gluba-Brzózka A, Pietruszyński R, Rysz J. Int Urol Nephrol; 2015 Dec 11; 47(12):2003-12. PubMed ID: 26494632 [Abstract] [Full Text] [Related]
40. Coronary artery calcification in patients with diabetes mellitus and advanced chronic kidney disease. Cano-Megías M, Bouarich H, Guisado-Vasco P, Pérez Fernández M, de Arriba-de la Fuente G, Álvarez-Sanz C, Rodríguez-Puyol D. Endocrinol Diabetes Nutr (Engl Ed); 2019 May 11; 66(5):297-304. PubMed ID: 30509882 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]